IMMUNE CHECKPOINT INHIBITOR AND HDAC INHIBITOR COMBINATION THERAPY STRATEGY Application WO-2022251827-A1 World Intellectual Property Organisation (WIPO) 01 Dec 2022
COMBINATION COMPRISING HDAC INHIBITOR, CTLA-4 INHIBITOR AND A PD-1 INHIBITOR OR PD-L1… Application WO-2021064188-A1 World Intellectual Property Organisation (WIPO) 08 Apr 2021